NANOFACTS aims to enhance the capacity of biosensing technologies at BIOS with research on cancer-related biosensing, including the construction of an array of user-friendly personalized point-of-care microfluidic and electronic diagnostic devices for electronic and optical sensing of cancer biomarkers (CB), which could be introduced to home disease-monitoring. Research efforts at BIOS will be also expanded to devising theranostic nanoparticles for real-time in vivo detection of cancer biomarkers, along with simultaneous targeted cancer therapy and imaging.

The application of nanotechnology in medicine offers new opportunities for overcoming the drawbacks of conventional therapy and for developing optimized diagnostic tools. The main research subject to be explored under this project is the construction of complex nanodevices for performing different functions at the same time, such as combined targeted therapy and imaging of cancer along with real-time CB-sensing.


This project has received funding from the European Union’s Horizon 2020 research
and innovation programme under grant agreement No 952259.

2021 Nanofacts –  Design by Studio digital